Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-28

Clinical Trial Update: Magnetic Seizure Therapy (MST) for Severe Mood Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Magnetic Seizure Therapy for severe mood disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnetic Seizure Therapy

Snippet

Sponsor: Sarah Lisanby | Conditions: Depression | Phase 3 | Status: COMPLETED